Cargando…

Use of a Unique Mobile Medical Asset in COVID Monoclonal Antibody Treatment

The COVID-19 pandemic and the subsequent surge of patients presented to emergency departments has forever changed the paradigm of delivering emergency care. The highly infectious nature of the 2019 Novel Coronavirus, or COVID-19, mandated strict environmental changes, novel patient care, and flexibl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morchel, Herman, Clark, David, Buenvenida, Leighanne, Ogedegbe, Chinwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393710/ https://www.ncbi.nlm.nih.gov/pubmed/34442127 http://dx.doi.org/10.3390/healthcare9080990

Ejemplares similares

Development and evaluation of a novel, real time mobile telesonography system in management of patients with abdominal trauma: study protocol
por: Ogedegbe, Chinwe, et al.
Publicado: (2012)

Dyskinesia as a unique presentation of subarachnoid hemorrhage: a case report
por: Jaffery, Aleq, et al.
Publicado: (2023)

IgA Monoclonal Gammopathy of Undetermined Significance and Complication of Streptococcus mitis Bacteremia
por: Paterno, Jennifer, et al.
Publicado: (2020)

Investigating Alternative Container Formats for Lyophilization of Biological Materials Using Diphtheria Antitoxin Monoclonal Antibody as a Model Molecule
por: Malik, Kiran P., et al.
Publicado: (2021)

Unique Glycoform-Dependent Monoclonal Antibodies for Mouse Mucin 21
por: Nishida, Jun, et al.
Publicado: (2022)

Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients
por: Thümmler, Laura, et al.
Publicado: (2022)

Monoclonal antibodies as treatment for COVID-19
por: Medina Gamero, A., et al.
Publicado: (2022)

Development of Biodegradable Nanocarriers Loaded with a Monoclonal Antibody
por: Gdowski, Andrew, et al.
Publicado: (2015)

Electronic Health Records Access During a Disaster
por: Morchel, Herman, et al.
Publicado: (2014)

Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross- reacting antibodies
por: Gown, AM, et al.
Publicado: (1982)

Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
por: Halfmann, Peter J, et al.
Publicado: (2022)

Cytological Samples: An Asset for the Diagnosis and Therapeutic Management of Patients with Lung Cancer
por: Frankel, Diane, et al.
Publicado: (2023)

Improvement of Anti-CD36 Antibody Detection via Monoclonal Antibody Immobilization of Platelet Antigens Assay by Using Selected Monoclonal Antibodies
por: Xu, Xiuzhang, et al.
Publicado: (2023)

COVID-19: A unique opportunity to upgrade medical conferences
por: Zargaran, David, et al.
Publicado: (2020)

Monoclonal Antibody Therapy for COVID-19: A Retrospective Observational Study at a Regional Hospital
por: Pannier, Judith, et al.
Publicado: (2023)

Antibody Light Chains: Key to Increased Monoclonal Antibody Yields in Expi293 Cells?
por: Gong, Siqi, et al.
Publicado: (2022)

Establishment and Functional Characterization of Murine Monoclonal Antibodies Recognizing Neuritin
por: Papadogianni, Georgia, et al.
Publicado: (2023)

Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Children: Application of Allometric Scaling
por: Mahmood, Iftekhar
Publicado: (2020)

Neutralizing monoclonal antibodies for treatment of COVID-19
por: Taylor, Peter C., et al.
Publicado: (2021)

The Relevance of Monoclonal Antibodies in the Treatment of COVID-19
por: Torrente-López, Anabel, et al.
Publicado: (2021)

Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules
por: Rees, Jennifer, et al.
Publicado: (2017)

Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

In/Out Status Monitoring in Mobile Asset Tracking with Wireless Sensor Networks
por: Kim, Kwangsoo, et al.
Publicado: (2010)

Development of Mobile Mapping System for 3D Road Asset Inventory
por: Sairam, Nivedita, et al.
Publicado: (2016)

Obinutuzumab: A FDA approved monoclonal antibody in the treatment of untreated chronic lymphocytic leukemia
por: Sachdeva, Mamta, et al.
Publicado: (2015)

Enhanced Tumor Localization of Monoclonal Antibody by Treatment with Kininase II Inhibitor and Angiotensin II
por: Noguchi, Akinori, et al.
Publicado: (1992)

A Mobile Asset Tracking System Architecture under Mobile-Stationary Co-Existing WSNs
por: Kim, Tae Hyon, et al.
Publicado: (2012)

Mobile Affinity Selection Chromatography Analysis of Therapeutic Monoclonal Antibodies
por: Narsimhan, Meena L., et al.
Publicado: (2023)

Connectedness in cross-assets and digital assets attention indices
por: Barson, Zynobia, et al.
Publicado: (2023)

Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
por: Lombardi, Andrea, et al.
Publicado: (2023)

Digital asset management
por: Austerberry, David
Publicado: (2004)

Digital asset management
por: Austerberry, David
Publicado: (2006)

Hapten Design and Monoclonal Antibody to Fluoroacetamide, a Small and Highly Toxic Chemical
por: Yang, Ling, et al.
Publicado: (2020)

Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection
por: Romani, Lorenza, et al.
Publicado: (2022)

Role of monoclonal antibody drugs in the treatment of COVID-19
por: Ucciferri, Claudio, et al.
Publicado: (2020)

Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
por: Jaworski, Juan Pablo
Publicado: (2021)

Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody
por: Hinke, Simon A., et al.
Publicado: (2018)

535. Risk Factors for Seeking Medical Care Following Monoclonal Antibody Treatment For COVID-19
por: MALIK, I S M A I L O, et al.
Publicado: (2023)

Classification between Failed Nodes and Left Nodes in Mobile Asset Tracking Systems †
por: Kim, Kwangsoo, et al.
Publicado: (2016)

Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab)
por: Tebbey, Paul W, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_su48iqm9vansc43imshv63afhl